Yahoo
OTC Markets OTCPK - Delayed Quote USD

Inspire Veterinary Partners, Inc. (IVPR)

0.0002 +0.0001 (+100.00%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
15,560.0110 16,592.1090 16,675.3930 9,834.7780 2,549.1340
Cost of Revenue
-12,547.3270 -13,299.5610 -13,121.4780 -7,289.1500 -1,719.8440
Gross Profit
3,012.6840 3,292.5480 3,553.9150 2,545.6280 829.2900
Selling, General and Administrative Expenses
-10,855.5730 -11,421.3520 -9,476.2870 -5,467.6420 -1,792.0460
Depreciation, Amortization and Depletion
-1,124.6220 -1,308.6190 -1,252.5390 -596.1240 -84.4650
Operating Income/Expenses
-11,980.1950 -12,729.9710 -10,728.8260 -6,063.7660 -1,876.5110
Total Operating Profit/Loss
-8,967.5110 -9,437.4230 -7,174.9110 -3,518.1380 -1,047.2210
Total Net Finance Income/Expense
-1,682.6580 -3,098.2370 -2,538.6890 -1,424.2390 -194.6500
Irregular Income/Expenses
-1,292.4310 -1,723.8330 -943.1590 0 --
Other Income/Expense, Non-Operating
0 -4.7680 -4,136.1270 0.3570 -14.8610
Non-Operating Income/Expenses, Total
-2,975.0890 -4,826.8380 -7,617.9750 -1,423.8820 -209.5110
Pretax Income
-11,942.6000 -14,264.2610 -14,792.8860 -4,942.0200 -1,256.7320
Provision for Income Tax
0 0 0 30.0940 -74.3300
Net Income from Continuing Operations
-11,942.6000 -14,264.2610 -14,792.8860 -4,911.9260 -1,331.0620
Net Income after Extraordinary Items and Discontinued Operations
-11,942.6000 -14,264.2610 -14,792.8860 -4,911.9260 -1,331.0620
Net Income after Non-Controlling/Minority Interests
-11,942.6000 -14,264.2610 -14,792.8860 -4,911.9260 -1,331.0620
Preferred/Other Stock Distribution
0 -220.8500 -271.2450 0 --
Net Income Available to Common Stockholders
-11,942.6000 -14,485.1110 -15,064.1310 -4,911.9260 -1,331.0620
Diluted Net Income Available to Common Stockholders
-11,942.6000 -14,485.1110 -15,064.1310 -4,911.9260 -1,331.0620
Basic EPS
-38.00 -65.25 -8.75k -1.79k -484.20
Diluted EPS
-38.00 -65.25 -8.75k -1.79k -484.20
Basic Weighted Average Shares Outstanding
256.9990 222.0380 1.7240 2.7490 2.7490
Diluted Weighted Average Shares Outstanding
256.9990 222.0380 1.7240 2.7490 2.7490
Income Statement, Supplemental
EBIT
-10,259.9420 -11,166.0240 -12,254.1970 -3,517.7810 -1,062.0820
EBITDA
-8,841.1360 -9,498.4230 -10,839.3600 -2,908.1960 -978.1740
Normalized EBITDA
-7,409.4310 -7,750.9430 -9,893.5000 -2,908.1960 -978.1740
Normalized Income
-10,510.8950 -12,516.7810 -13,847.0260 -4,911.9260 -1,331.0620
Total Unusual Items
1,431.7050 1,747.4800 945.8600 0 0
Total Unusual Items Excluding Goodwill
1,431.7050 1,747.4800 945.8600 0 0
12/31/2021 - 8/30/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: